IL208765A0 - Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles - Google Patents

Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles

Info

Publication number
IL208765A0
IL208765A0 IL208765A IL20876510A IL208765A0 IL 208765 A0 IL208765 A0 IL 208765A0 IL 208765 A IL208765 A IL 208765A IL 20876510 A IL20876510 A IL 20876510A IL 208765 A0 IL208765 A0 IL 208765A0
Authority
IL
Israel
Prior art keywords
mitigating
compounds
methods
replikin count
count cycles
Prior art date
Application number
IL208765A
Original Assignee
Bogoch Samuel
Elenore S Bogoch
Samuel Winston Bogoch
Anne Elenore Borsanyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/108,458 external-priority patent/US9408902B2/en
Application filed by Bogoch Samuel, Elenore S Bogoch, Samuel Winston Bogoch, Anne Elenore Borsanyi filed Critical Bogoch Samuel
Publication of IL208765A0 publication Critical patent/IL208765A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL208765A 2008-04-23 2010-10-17 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles IL208765A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12/108,458 US9408902B2 (en) 2007-05-30 2008-04-23 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
PCT/US2008/061336 WO2008156914A2 (en) 2007-05-30 2008-04-23 Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
US5401008P 2008-05-16 2008-05-16
US8735408P 2008-08-08 2008-08-08
US14361809P 2009-01-09 2009-01-09
PCT/US2009/041565 WO2009132209A2 (en) 2008-04-23 2009-04-23 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles

Publications (1)

Publication Number Publication Date
IL208765A0 true IL208765A0 (en) 2010-12-30

Family

ID=41066049

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208765A IL208765A0 (en) 2008-04-23 2010-10-17 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles

Country Status (6)

Country Link
EP (1) EP2300493A2 (en)
JP (1) JP2011519837A (en)
AU (1) AU2009240587A1 (en)
CA (1) CA2720465A1 (en)
IL (1) IL208765A0 (en)
WO (1) WO2009132209A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
WO2013013075A2 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
SG11201405447QA (en) 2012-03-09 2014-10-30 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
EP1419175B1 (en) * 2001-03-27 2011-04-27 Samuel Dr. Bogoch Replikin peptides and uses thereof
EP2390804A3 (en) * 2004-04-28 2012-02-29 Samuel Bogoch System and method for identifying complex patterns of amino acids
CA2598381A1 (en) * 2005-02-16 2006-08-24 Samuel Bogoch Replikin peptides and uses thereof
CN101365484A (en) * 2005-08-15 2009-02-11 瓦克辛公司 Immunization of avians by administration of non-replicating vectored vaccines
BRPI0713671A2 (en) * 2006-06-16 2013-12-03 Dow Agrosciences Llc DNA SEQUENCES, VECTORS AND PROTEINS OF HEMAGLUTININ FROM AVIAN INFLUENZA

Also Published As

Publication number Publication date
EP2300493A2 (en) 2011-03-30
AU2009240587A1 (en) 2009-10-29
WO2009132209A3 (en) 2010-03-18
CA2720465A1 (en) 2009-10-29
WO2009132209A2 (en) 2009-10-29
JP2011519837A (en) 2011-07-14

Similar Documents

Publication Publication Date Title
ZA201100717B (en) Cycle
EP2335741A4 (en) Isolator
ZA201009076B (en) Novel synergistic effects
GB0817376D0 (en) Workholding device
PT3608322T (en) Syringe containing nmtx bromide
EP2339271A4 (en) Cooling cycle device
EP2347418A4 (en) Logical unit operation
PL2145914T3 (en) Softener preparations
GB0822068D0 (en) Methods for virus design
EP2263136A4 (en) Software-based power-capping
IL234296B (en) Dosing regimen
ZA201004989B (en) Phenyl acetamide derivative
GB0820950D0 (en) Funnel
ZA201004926B (en) Multi-travel aggregator
EP2259925A4 (en) Improved flexo cushion
EP2301996A4 (en) Modifying composition for asplalt-concrete mixtures
GB0917939D0 (en) Manual-lift machine
HK1154218A1 (en) Steriliser unit
IL208765A0 (en) Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
GB0821062D0 (en) Frames
GB0808926D0 (en) Safe cycles
TWI372694B (en) Motorcycle
IL209511A (en) Methods for preparing plasmin
EP2304401A4 (en) High throughput birefringence measurement
GB2465340B (en) Holberry frame